---
figid: PMC7283209__11523_2020_717_Fig2_HTML
figtitle: Illustration of the possibilities to target and alter the expression level
  of long non-coding RNAs (lncRNAs)
organisms:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7283209
filename: 11523_2020_717_Fig2_HTML.jpg
figlink: pmc/articles/PMC7283209/figure/Fig2/
number: F2
caption: Illustration of the possibilities to target and alter the expression level
  of long non-coding RNAs (lncRNAs). a Nuclear localised lncRNAs can be targeted by
  chemically modified antisense oligonucleotides (ASOs) resulting in RNAseH-dependent
  degradation. b Antisense oligonucleotides or small-molecule inhibitors can be used
  to inhibit the lncRNA-RNA-binding protein interactions. c Long non-coding RNA expression
  can be modulated via steric blocking of the promoter or by using genome-editing
  techniques such as CRISPR/Cas9 [–]. d Up-regulation of lncRNA expression can be
  mediated by knock-down of the relevant corresponding natural antisense transcripts
  (NATs). e Long non-coding RNAs present in the cytoplasm can be degraded with small
  interfering RNA (siRNA)-based strategies involving the multiprotein complex RISC,
  RNAse dicer and endonuclease Argonaut2-dependent degradation pathway
papertitle: 'MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for
  Cancer Therapy: First Steps from Bench to Bedside.'
reftext: Margherita Ratti, et al. Target Oncol. 2020;15(3):261-278.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9562626
figid_alias: PMC7283209__F2
figtype: Figure
redirect_from: /figures/PMC7283209__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7283209__11523_2020_717_Fig2_HTML.html
  '@type': Dataset
  description: Illustration of the possibilities to target and alter the expression
    level of long non-coding RNAs (lncRNAs). a Nuclear localised lncRNAs can be targeted
    by chemically modified antisense oligonucleotides (ASOs) resulting in RNAseH-dependent
    degradation. b Antisense oligonucleotides or small-molecule inhibitors can be
    used to inhibit the lncRNA-RNA-binding protein interactions. c Long non-coding
    RNA expression can be modulated via steric blocking of the promoter or by using
    genome-editing techniques such as CRISPR/Cas9 [–]. d Up-regulation of lncRNA expression
    can be mediated by knock-down of the relevant corresponding natural antisense
    transcripts (NATs). e Long non-coding RNAs present in the cytoplasm can be degraded
    with small interfering RNA (siRNA)-based strategies involving the multiprotein
    complex RISC, RNAse dicer and endonuclease Argonaut2-dependent degradation pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - SCPEP1
  - AGO2
  - cas
  - caz
  - Cse1
  - cass
  - cash
  - tt
  - CG43373
---
